Question to the Department of Health and Social Care:

To ask Her Majesty's Government what arrangements they are seeking to put in place following Brexit to ensure the timely availability of medicines manufactured in EU countries to patients in the UK.

The Government is fully aware of the importance of medicines to patients in the United Kingdom and is considering the implications of exit from the European Union on the supply of pharmaceuticals as a high priority. The Department is working closely with others across Government to assess the impact of leaving the EU on the supply chain for all medicines and medical radioisotopes used in the National Health Service and to minimise any risk of disruption.